ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

13.98 +0.35 (+2.60%)

Streaming Delayed Price Updated: 2:04 PM EDT, Apr 27, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	17,992,270
Open	14.23
Bid (Size)	13.98 (300)
Ask (Size)	13.99 (100)
Prev. Close	13.63
Today's Range	13.68 - 14.75
52wk Range	6.830 - 28.25
Shares Outstanding	88,140,978
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Biotech Stocks That Could Benefit from the Patent Cliff ↗

Today 7:05 EDT

Via MarketBeat

Top movers in Friday's after hours session ↗

April 24, 2026

Via Chartmill

Performance

YTD	+51.8%	+51.8%
1 Month	+13.1%	+13.1%
3 Month	+0.3%	+0.3%
6 Month	-5.4%	-5.4%
1 Year	+64.9%	+64.9%

More News

2 Healthcare Stocks to Buy and 1 to Approach With Caution ↗

April 15, 2026

Via The Motley Fool

This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy? ↗

March 08, 2026

Via The Motley Fool

Intellia Therapeutics Inc (NASDAQ:NTLA) Reports Strong Q4 2025 Revenue Beat and Confirms Key 2026 Pipeline Milestones ↗

February 26, 2026

Via Chartmill

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

March 03, 2026

Via The Motley Fool

Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone

March 03, 2026

Via FinancialNewsMedia

Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗

March 02, 2026

Via Stocktwits

Intellia (NTLA) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy? ↗

February 07, 2026

Via The Motley Fool

NTLA Stock Jumped 13% Today – What Is The Latest FDA Action All About? ↗

January 27, 2026

Via Stocktwits

Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗

January 16, 2026

Via Stocktwits

Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗

January 16, 2026

Via Stocktwits

Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares ↗

January 12, 2026

Via The Motley Fool

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

Via MarketMinute

2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗

December 29, 2025

Via The Motley Fool

How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗

December 02, 2025

Via Investor's Business Daily

Intellia (NTLA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

Via FinancialNewsMedia

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

From MarketNewsUpdates.com

Via GlobeNewswire

2 Beaten-Down Stocks to Avoid Right Now ↗

November 15, 2025

Via The Motley Fool

This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday ↗

November 12, 2025

Via Benzinga

This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday ↗

November 11, 2025

Via Benzinga

What 21 Analyst Ratings Have To Say About Intellia Therapeutics ↗

November 11, 2025

Via Benzinga

Why Gene-Editing Giants Crispr And Intellia Just Surged ↗

November 10, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?

Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?

Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?

The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market

What is the current price of Intellia Therapeutics, Inc. - Common Stock?

The current price of Intellia Therapeutics, Inc. - Common Stock is 13.98

When was Intellia Therapeutics, Inc. - Common Stock last traded?

The last trade of Intellia Therapeutics, Inc. - Common Stock was at 04/27/26 02:04 PM ET

What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?

The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.23B

How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?

Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.